The Lipid Profile and Mortality Risk in Elderly Type 2 Diabetic Patients: A Ten-Year Follow-Up Study (ZODIAC-13)
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: The precise relationship between the lipid profile and mortality in elderly patients with type 2 diabetes mellitus (T2DM) remains unclear. The aim of this study was to investigate the relationship between the lipid profile over time, and mortality in elderly patients with T2DM. METHODS AND FINDINGS: In 1998, 881 primary care patients with T2DM aged 60 years and older participated in the ZODIAC study, a prospective observational study. The cohort was divided into two age categories: 60-75 years and older than 75 years. Updated means of all lipid profile indices were calculated after a median follow-up time of 9.8 years. These values were used as time dependent covariates in a Cox proportional hazard model. The cholesterol-HDL ratio and LDL-cholesterol were positively related to both all-cause and cardiovascular mortality in the low age group. In contrast, except for the triglyceride level, none of the other lipid profile indices were related to all-cause mortality in patients aged over 75 years. The mortality risk decreased by 17% (95%CI: 5% to 27%) for each 1 mmol/L higher serum level of triglycerides. The relationships between the various lipid profile indices and cardiovascular mortality were not significant. However, the results were different after stratification for diabetes duration. In the subgroup of elderly patients with a diabetes duration of 8 years and longer, higher lipids were predictive of increased cardiovascular mortality. The main limitation of this study is its observational design, which prevents us drawing conclusions about causality. CONCLUSION: Although the lipid profile was not predictive in the overall group of elderly patients, higher lipids were related to increased cardiovascular mortality in patients with diabetes of long duration. In order to make valid recommendations concerning lipid-lowering treatment, a randomized controlled trial or a meta-analysis concerning this specific population is mandatory.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In a longitudinal study of 881 patients with T2DM over 10 years, van Hateren et al. [8] indicated that the hazard ratio for death due to CVD was constantly increasing each year.”
From Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017 (2018) · cites this paper as [8]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Friedewald, W. T., Levy, R. I., & Fredrickson, D. S. (1972) · Clinical Chemistry · doi:10.1093/clinchem/18.6.499 · Cited by 32,423
Grundy, S. M., Cleeman, J. I., Merz, C. N. B., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Circulation · doi:10.1161/01.cir.0000133317.49796.0e · Cited by 6,902
Stamler, J., Vaccaro, O., Neaton, J. D., Wentworth, D., & The Multiple Risk Factor Intervention Trial Research Group (1993) · Diabetes Care · doi:10.2337/diacare.16.2.434 · Cited by 4,063
Shepherd, J., Blauw, G. J., Murphy, M. B., Bollen, E. L., Buckley, B. M., Cobbe, S. M., Ford, I., Gaw, A., Hyland, M., Jukema, J. W., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)11600-x · Cited by 3,378 · cited 2×
“The risk of cardiovascular disease was not reduced in patients with a history of diabetes, although the number of patients with diabetes was probably too small to permit accurate interpretation of the treatment effect [8].”
BackgroundSelf-citationDe Backer, G. (2003) · European Heart Journal · doi:10.1016/s0195-668x(03)00347-6 · Cited by 2,251
Adler, A. I. (2000) · BMJ · doi:10.1136/bmj.321.7258.412 · Cited by 2,133 · cited 1×
“This technique is similar to the one used in the United Kingdom Prospective Diabetes Study (UKPDS) [17].”
MethodCollaborators, C. T. T. (. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60104-x · Cited by 2,081
Turner, R. C., Millns, H., Neil, H. A. W., Stratton, I. M., Manley, S. E., Matthews, D. R., & Holman, R. R. (1998) · BMJ · doi:10.1136/bmj.316.7134.823 · Cited by 2,014
Grundy, S. M., Cleeman, J. I., Bairey Merz, C. N., Brewer, H. B., Clark, L. T., Hunninghake, D. B., Pasternak, R. C., Smith, S. C., & Stone, N. J. (2004) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2004.07.001 · Cited by 1,550
Cited by
Einarson, T. R., Acs, A., Ludwig, C., & Panton, U. H. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0728-6 · Cited by 2,312
“[8] indicated that the hazard ratio for death due to CVD was constantly increasing each year.”
BackgroundPrecision subclassification of type 2 diabetes: a systematic review
Misra, S., Wagner, R. J., Özkan, B., Schön, M., Sevilla-González, M. D. R., Prystupa, K., Wang, C. C., Kreienkamp, R. J., CROMER, S. J., Rooney, M. R., et al. (2023) · Communications Medicine · doi:10.1038/s43856-023-00360-3 · Cited by 152
Zhou, D., Liu, X., Kenneth, L., Huang, Y., & Feng, Y. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.778038 · Cited by 69
“The mortality risk decreased by 17% for each 1 mmol/L increase serum level of TG in ZODIAC study (20).”
BackgroundSone, H., Tanaka, S., Tanaka, S., Iimuro, S., Ishibashi, S., Oikawa, S., Shimano, H., Katayama, S., Ohashi, Y., Akanuma, Y., et al. (2012) · Diabetes Care · doi:10.2337/dc11-1412 · Cited by 57
van Hateren, K. J. J., Drion, I., Kleefstra, N., Groenier, K. H., Houweling, S. T., van der Meer, K., & Bilo, H. J. G. (2012) · BMJ Open · doi:10.1136/bmjopen-2012-001387 · Cited by 49
Self-citationWang, Y., Lammi‐Keefe, C. J., Hou, L., & Hu, G. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.07.009 · Cited by 49
“study [34] used updated mean LDL cholesterol levels and”
BackgroundMethodInfluentialLi, X., Guan, B., Wang, Y., Tse, G., Zou, F., Waleed, K. B., Xia, Y., Wu, S., & Sun, J. (2019) · Scientific Reports · doi:10.1038/s41598-019-50924-4 · Cited by 49
Hashemi, R., Rabizadeh, S., Yadegar, A., Mohammadi, F., Rajab, A., Reyhan, S. K., Seyedi, S. A., Esteghamati, A., & Nakhjavani, M. (2024) · BMC Geriatrics · doi:10.1186/s12877-024-05483-3 · Cited by 38
A prospective study of risk factors for cardiovascular events among the elderly
Cabrera, M. A. S., Mesas, A. E., & de Andrade, S. M. (2012) · Clinical Interventions in Aging · doi:10.2147/cia.s37211 · Cited by 29
Roelofsen, Y., Hendriks, S. H., Sieverink, F., van Vugt, M., van Hateren, K. J., Snoek, F. J., de Wit, M., Gans, R. O. B., Groenier, K. H., van Gemert‐Pijnen, J. E. W. C., et al. (2014) · BMC Endocrine Disorders · doi:10.1186/1472-6823-14-22 · Cited by 19
“This prospective observational study should be considered the continuation of the Zwolle Outpatient Diabetes Project Integrating Available Care (ZODIAC) started in 1997 [19-25].”
BackgroundSelf-citationHulkoti, V. S., Acharya, S., Shukla, S., Kumar, S., Kabra, R., Dubey, A., Lahane, V., & Giri, A. (2022) · Cureus · doi:10.7759/cureus.31279 · Cited by 23
“001) were significantly associated with microvascular complications in DM patients marked by microalbuminuria and altered serum creatinine values [28].”
Backgroundvan Hateren, K. J. J., Landman, G. W. D., Kleefstra, N., Groenier, K. H., Struck, J., Navis, G. J., Bakker, S. J. L., Houweling, S. T., van der Meer, K., & Bilo, H. J. G. (2012) · Diabetes Care · doi:10.2337/dc12-0428 · Cited by 15
Self-citationChi, M., Liang, C., Lee, W., Peng, L., Chou, M.-Y., & Chen, L. (2016) · The journal of nutrition health & aging · doi:10.1007/s12603-016-0751-9 · Cited by 16
“A recent study indicated that lipid profile was not predictive of cardiovascular mortality in older patients with DM(20).”
Health outcomes in diabetics measured with Minnesota Community Measurement quality metrics
Takahashi, P. Y., Sauver, J. L. S., Rutten, L. F., Jacobson, R. M., Jacobson, D., McGree, M., & Ebbert, J. O. (2014) · Diabetes Metabolic Syndrome and Obesity · doi:10.2147/dmso.s71726 · Cited by 11
Zhou, X., Park, J., Rolka, D. B., Holliday, C. S., Choi, D., & Zhang, P. (2025) · Preventing Chronic Disease · doi:10.5888/pcd22.240270 · Cited by 13
The eSS rat, a nonobese model of disordered glucose and lipid metabolism and fatty liver
Daniele, S. M., Montenegro, S. M., Tarrés, M. C., Picena, J. C., & Martínez, S. M. (2010) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-2-15 · Cited by 9
Lavalle-Cobo, A., Masson, W., Lobo, M., Masson, G., & Molinero, G. (2021) · High Blood Pressure & Cardiovascular Prevention · doi:10.1007/s40292-021-00479-1 · Cited by 9
Zhang, X., Lin, S., Zeng, Q., Peng, L., & Yan, C. (2025) · Frontiers in Nutrition · doi:10.3389/fnut.2025.1612369 · Cited by 19
Lipoprotein ( a ) and Atherogenic Indices in Sudanese Patients with Type 2 Diabetes
Mohieldein, A., Abdalla, K. E., & Hasan, M. (2014) · International Journal of Health Sciences · doi:10.12816/0023976 · Cited by 11
“(29) Elevated serum levels of LDL-C and TG and low levels of HDL-C are strongly associated with increased risk for macrovascular events (e.”
BackgroundPohjantähti‐Maaroos, H., Palomäki, A., Kankkunen, P., Husgafvel, S., Knuth, T., Vesterinen, K., & Oksanen, K. (2011) · Annals of Medicine · doi:10.3109/07853890.2011.590520 · Cited by 8
“Elevated levels of LDL cholesterol and triglycerides are known to be independent risk factors for CVD events (37,38).”
BackgroundManagement of dyslipidaemias in the elderly population—A narrative review
Anagnostis, P. G., Vaitsi, K., Veneti, S., Georgiou, T., Paschou, S. Α., Lambrinoudaki, I. V., & Goulis, D. G. (2019) · Maturitas · doi:10.1016/j.maturitas.2019.03.011 · Cited by 10
Fiore, V., Barucca, A., Barraco, S., Triggiani, D., Tragni, D., Piazzolla, G., Triggiani, V., Carbotta, G., & Lisco, G. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230428092828 · Cited by 9
Priyadarsini, N., Likhitha, D., Ramachandran, M., & Behera, K. K. (2023) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2023.12.003 · Cited by 3
Amerzadeh, M., Bahrami, M., Senmar, M., Hosseinkhani, Z., & Kisomi, Z. S. (2025) · Discover Public Health · doi:10.1186/s12982-025-00403-1 · Cited by 1
“According to the Extended Parallel Processing Model, information avoidance tends to occur when individuals experience high levels of fear regarding health threats (such as the risk of a heart attack) but lack the belief that they can manage these threats effectively (i.e., low efficacy) [9, 10].”
Shriya, A. S. K., Pawar, V. B., & Paul, A. A. (2024) · Current Diabetes Reviews · doi:10.2174/0115733998305019240702095537 · Cited by 2
Impact of Disease Duration on Lipid Profile in Type 2 Diabetes Mellitus Patients
Thagele, S. N. (2018) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v6i9.122 · Cited by 1
“mellitus and was associated with increased cardiovascular risk [13] .”
BackgroundShetty, P., Shetty, S., Shashikiran, H. C., & Rajany, T. (2021) · Advances in Integrative Medicine · doi:10.1016/j.aimed.2021.07.002 · Cited by 1
Triches, C. B. (2010) · Lume (Universidade Federal do Rio Grande do Sul)
Weight loss and cholesterol lowering in the elderly.
Rolland, C., & Broom, J. I. (2010) · Open Access Institutional Repository at Robert Gordon University (Robert Gordon University)
Landman, G. W. D., van Hateren, K., Kleefstra, N., & Bilo, H. J. G. (2010) · British Journal of General Practice · doi:10.3399/bjgp10x514873
Self-citationMohieldein, A. (2016) · Journal of Advances in Medicine and Medical Research · doi:10.9734/bjmmr/2016/28170
Cobo, A. L., Masson, W. M., Lobo, M., Masson, G., & Molinero, G. B. (2021) · Research Square · doi:10.21203/rs.3.rs-664920/v1
Poochanasri, M., Kookanok, C., Rangsin, R., Kaewput, W., Mungthin, M., & Samakkarnthai, P. (2026) · Scientific Reports · doi:10.1038/s41598-026-53714-x
Metadata
- Authors
- van Hateren, K. J. J., Landman, G. W. D., Kleefstra, N., Logtenberg, S. J. J., Groenier, K. H., Kamper, A. M., Houweling, S. T., & Bilo, H. J. G.
- Affiliations
- Isala (NL)
- University Medical Center Groningen (NL)
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2009-12-24
- Volume
- 4
- Issue
- 12
- Pages
- e8464
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC2795197
- OpenAlex
- W2098852684
- Cited by
- 34
- References
- 28
- Citations by year
- 2026: 1 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 2 · 2021: 3 · 2019: 3 · 2018: 2 · 2016: 2 · 2014: 3 · 2013: 1 · 2012: 4
- FWCI
- 2.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion)
- University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Keywords
- type 2 diabetes, elderly patients, lipid profile, mortality risk, cardiovascular mortality, all-cause mortality, TC/HDL-C ratio, LDL cholesterol, triglycerides, diabetes duration, lipid-lowering therapy
- MeSH terms
- Aged, Aged, 80 and over, Diabetes Mellitus, Type 2, Female, Follow-Up Studies, Humans, Lipids, Male, Netherlands, Risk Factors, Time Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.